… combination of cabotegravir and rilpivirine (CAB plus RPV) … treatment discontinuation occurred more frequently in people with HIV … October 21, 2025, in HIV Medicine. LIMITATIONS: The ambispective … from ViiV Healthcare, Janssen Pharmaceuticals, and/or …

… North Carolina School of Medicine, Chapel Hill, and … or in patients receiving rilpivirine-containing products. For information … hypomagnesemia or drugs that may cause hypomagnesemia. Treatment of … Pharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA …

… The trial started treatment-naïve participants on a 3-drug oral HIV treatment … pill burden; however, select medications remain contraindicated for use with some HIV treatment … of cabotegravir and rilpivirine over 48 weeks. AIDS Behav. 2020;24(12):3533- …

… to simplify treatment, reduce drug interactions, and … FDA-approved long-acting injectable, coformulated cabotegravir plus rilpivirine … interactions between HIV medications and multivalent … trial (NCT02344290) showed that initiating statins in patients with HIV …

… , among Medicare beneficiaries with HIV. Using claims data, the study included treatment-experienced … people with HIV aged 18 or older covered by Medicare … /TAF, or cabotegravir plus rilpivirine (CAB+RPV) between July 2017 …

… , Professor of Medicine, Weill Cornell Medicine and study author … for Phathom Pharmaceuticals. “This large, randomized trial provides … or in patients receiving rilpivirine-containing products. WARNINGS … or drugs that may cause hypomagnesemia. Treatment of …

… Esophageal Center, Northwestern Medicine, Northwestern University Phathom … or in patients receiving rilpivirine-containing products. WARNINGS … or drugs that may cause hypomagnesemia. Treatment of … Pharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA …

… not contain the HBV treatment tenofovir. HBV Reactivation … infectious diseases/HIV medicine at the Royal Free … that hepatitis B vaccination remains essential for individuals … HIV Switching From HBV-Active ART to Long-Acting Cabotegravir/Rilpivirine …

… mouth, for example a medicine taken by mouth. … drug resistance, poor adherence to an HIV treatment regimen or interrupting treatment. … trials in which CAB/RPV was compared to a three-drug … rilpivirine: an analysis based on reported cases. 20th European AIDS …

… the most gender-diverse HIV prevention trial to date – … Alafenamide From Cabotegravir + Rilpivirine: Results From the Phase … HIV treatment that combines three powerful medicines to form the smallest 3-drug … patients in clinical trials and large real- …